BR0014000A - Derivados de benzisoxazolila-, piridoisoxazolila- e benztienila-fenóxi úteis como antagonistas de d4 - Google Patents

Derivados de benzisoxazolila-, piridoisoxazolila- e benztienila-fenóxi úteis como antagonistas de d4

Info

Publication number
BR0014000A
BR0014000A BR0014000-7A BR0014000A BR0014000A BR 0014000 A BR0014000 A BR 0014000A BR 0014000 A BR0014000 A BR 0014000A BR 0014000 A BR0014000 A BR 0014000A
Authority
BR
Brazil
Prior art keywords
antagonists
derivatives useful
disorder
compounds
pyridoisoxazolyl
Prior art date
Application number
BR0014000-7A
Other languages
English (en)
Inventor
Gregory M Shutske
James A Hendrix
John G Jurcak
Brian S Freed
Nicholas J Hrib
John D Tomer Iv
Reda G Hanna
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of BR0014000A publication Critical patent/BR0014000A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/48—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Patente de Invenção: "DERIVADOS DE BENZISOXAZOLILA-, PIRIDOISOXAZOLILA- E BENZTIENILA-FENóXI úTEIS COMO ANTAGONISTAS DE D~ 4~". Os compostos são da classe derivados de benzisoxazolila, piridoisoxazolila, e benztienila-fenóxi, úteis como antagonistas de D~ 4~. Ditos compostos são úteis para o tratamento de condições médicas mediadas por inibição de receptor D~ 4~. Estas condições compreendem, por exemplo, Distúrbio de Hiperatividade de Déficit de Atenção, Distúrbio Compulsivo Obsessivo, Psicoses, Abuso de Substâncias, Dependência de Substâncias, mal de Parkinson, Parkinsonismo, Discinesia Tardia, Síndrome de Gilles de Ia Tourette, Distúrbio de Conduta, e Distúrbio Desafiador Oposicional. Um aspecto adicional da invenção é para fornecer uma composição farmacêutica, intermediários, e um método para produzir dita classe de compostos.
BR0014000-7A 1999-09-14 2000-09-13 Derivados de benzisoxazolila-, piridoisoxazolila- e benztienila-fenóxi úteis como antagonistas de d4 BR0014000A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39593799A 1999-09-14 1999-09-14
PCT/US2000/024961 WO2001019821A1 (en) 1999-09-14 2000-09-13 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists

Publications (1)

Publication Number Publication Date
BR0014000A true BR0014000A (pt) 2002-05-14

Family

ID=23565162

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014000-7A BR0014000A (pt) 1999-09-14 2000-09-13 Derivados de benzisoxazolila-, piridoisoxazolila- e benztienila-fenóxi úteis como antagonistas de d4

Country Status (24)

Country Link
EP (1) EP1216244B1 (pt)
JP (1) JP4806149B2 (pt)
KR (1) KR20020027648A (pt)
AT (1) ATE247110T1 (pt)
AU (1) AU7479400A (pt)
BR (1) BR0014000A (pt)
CA (1) CA2383332C (pt)
CZ (1) CZ2002898A3 (pt)
DE (1) DE60004543T2 (pt)
DK (1) DK1216244T3 (pt)
EA (1) EA200200356A1 (pt)
EE (1) EE200200134A (pt)
ES (1) ES2200934T3 (pt)
HR (1) HRP20020219A2 (pt)
HU (1) HUP0202706A3 (pt)
IL (1) IL148622A0 (pt)
MX (1) MXPA02002694A (pt)
NO (1) NO20021256L (pt)
NZ (1) NZ517516A (pt)
PL (1) PL354514A1 (pt)
PT (1) PT1216244E (pt)
SK (1) SK3492002A3 (pt)
WO (1) WO2001019821A1 (pt)
ZA (1) ZA200201757B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1717235A3 (en) * 2005-04-29 2007-02-28 Bioprojet Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
GB201004311D0 (en) 2010-03-15 2010-04-28 Proximagen Ltd New enzyme inhibitor compounds
EP2755974A1 (en) 2011-09-14 2014-07-23 Proximagen Limited New enzyme inhibitor compounds
EP3406607A1 (en) 2012-12-21 2018-11-28 Epizyme, Inc. Prmt5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
UA118548C2 (uk) 2012-12-21 2019-02-11 Епізайм, Інк. Тетрагідро- та дигідроізохіноліни як інгібітори prmt5 та їх застосування
CA2894157A1 (en) 2012-12-21 2014-06-26 Epizyme, Inc. Prmt5 inhibitors and uses thereof
JP2016505000A (ja) 2012-12-21 2016-02-18 エピザイム，インコーポレイティド Ｐｒｍｔ５阻害剤およびその使用
US9611257B2 (en) 2012-12-21 2017-04-04 Epizyme, Inc. PRMT5 inhibitors and uses thereof
WO2015200680A2 (en) * 2014-06-25 2015-12-30 Epizyme, Inc. Prmt5 inhibitors and uses thereof
EP3177288A4 (en) 2014-08-04 2018-04-04 Epizyme, Inc. Prmt5 inhibitors and uses thereof
WO2017205766A1 (en) 2016-05-27 2017-11-30 Pharmacyclics Llc Inhibitors of interleukin-1 receptor-associated kinase

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114936A (en) * 1990-08-23 1992-05-19 Hoechst-Roussel Pharmaceuticals Incorporated 6,7-dihydro-3-phenyl-1,2-benzisoxazol-4(5h)-ones and -ols, compositions and pharmaceutical use
US5147881A (en) * 1990-11-14 1992-09-15 Pfizer Inc 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents
US5177088A (en) * 1991-04-17 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Substituted 3-(pyridinylamino)-indoles
US5225412A (en) * 1991-04-29 1993-07-06 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
US5576319A (en) * 1993-03-01 1996-11-19 Merck, Sharp & Dohme Ltd. Pyrrolo-pyridine derivatives
CN1061350C (zh) * 1995-12-21 2001-01-31 美国辉瑞有限公司 2,7－取代的八氢－吡咯并[1,2－a]吡嗪衍生物
WO1997040027A1 (en) * 1996-04-19 1997-10-30 Akzo Nobel N.V. Substituted benzylamines and their use for the treatment of depression
FR2749304B1 (fr) * 1996-06-04 1998-06-26 Adir Nouveaux derives du 3-(piperid-4-yl)1,2-benzisoxazole et du 3-(piperazin-4-yl)1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
JPH1095770A (ja) * 1996-09-20 1998-04-14 Taisho Pharmaceut Co Ltd ４−ベンジリデンピペリジン誘導体
ATE367389T1 (de) * 1998-02-09 2007-08-15 Duphar Int Res Benzisoxazolderivate mit d4-antagonistischer wirkung

Also Published As

Publication number Publication date
EE200200134A (et) 2003-04-15
PL354514A1 (en) 2004-01-26
EA200200356A1 (ru) 2002-10-31
NZ517516A (en) 2003-11-28
ATE247110T1 (de) 2003-08-15
CZ2002898A3 (cs) 2002-07-17
AU7479400A (en) 2001-04-17
EP1216244B1 (en) 2003-08-13
CA2383332C (en) 2006-01-10
ES2200934T3 (es) 2004-03-16
ZA200201757B (en) 2003-08-27
PT1216244E (pt) 2003-12-31
HUP0202706A2 (hu) 2002-12-28
HRP20020219A2 (en) 2004-04-30
EP1216244A1 (en) 2002-06-26
CA2383332A1 (en) 2001-03-22
WO2001019821A1 (en) 2001-03-22
DE60004543D1 (de) 2003-09-18
DE60004543T2 (de) 2004-06-17
JP4806149B2 (ja) 2011-11-02
DK1216244T3 (da) 2003-11-17
KR20020027648A (ko) 2002-04-13
MXPA02002694A (es) 2002-07-30
NO20021256D0 (no) 2002-03-13
SK3492002A3 (en) 2002-12-03
HUP0202706A3 (en) 2004-12-28
IL148622A0 (en) 2002-09-12
NO20021256L (no) 2002-05-14
JP2003509421A (ja) 2003-03-11

Similar Documents

Publication Publication Date Title
BR0014000A (pt) Derivados de benzisoxazolila-, piridoisoxazolila- e benztienila-fenóxi úteis como antagonistas de d4
TW200531692A (en) Aryl aniline derivatives as β2 adrenergic receptor agonists
MXPA05013364A (es) Procedimiento para preparar 3-benzazepinas.
MA29088B1 (fr) Composes d'indazole-carboxamide.
BRPI0908738A8 (pt) Composto, medicamento, uso de um composto, e, processo para preparar os compostos
BRPI0607309A2 (pt) processos para a preparação de fenilpirazol uréias substituìdas
BR0014515A (pt) Derivados de propil tienoisoxazolil- e tienilpirrazolil-fenóxi substituìdos úteis como antagonistas de d4
UA96447C2 (ru) Полиморфные формы (2s)-(4e)-n-метил-5-[3-(5-изопропоксипиридин)ил]-4-пентен-2-амина для лечения расстройств центральной нервной системы
BRPI0607456A2 (pt) derivados de oxindol como agonistas do receptor 5ht4
EA201190004A1 (ru) Конденсированные имидазол карбоксамиды в качестве модуляторов trpv3
UA104188C2 (en) Gpr 119 agonists
MX2010004003A (es) N-fenil-pirrolidinilmetlipirrolidin amidas sustituidas y uso terapeutico de las mismas.
MX2010005704A (es) Derivados de cromano como modulares del trpv3.
WO2006052889A3 (en) Quinolinone-carboxamide compounds
UA104861C2 (uk) Похідні хроману як модулятори trpv3
BR0014513A (pt) Derivados de etila e propila insubstituìdos por fenóxi de tienoisoxazol úteis como antagonistas de d4
WO2007042544A3 (en) Imidazole derivatives and their use for modulating the gabaa receptor complex
AU2016263510B2 (en) Novel azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission
BRPI0415899A (pt) usos de um composto, e de um antagonista de receptor de h3, agonista inverso ou agonista parcial, composição farmacêutica, método para a identificação de compostos úteis para o tratamento de doenças, e, composto
NO20073732L (no) Arylpiperazinderivater og anvendelse derav som 5-HT1A-receptorligander
EA200970672A1 (ru) Соединения с комбинацией каннабиноид-свантагонизма и ингибирования обратного захвата серотонина
TH75845A (th) สารประกอบควิโนลิโนน-คาร์บอกแซมีดในฐานะเป็นแอกอนิสท์ของตัวรับ 5-ht4
WO2008093920A3 (en) 1,2-dihydro-1-oxophthalazinyl derivatives having biological activity on serotonin receptors 5-ht2a and 5-ht2c, and preparation thereof
TH106305A (th) สารประกอบที่มีสารรวมของแคนนาบินอยด์-cb1 แอนทาโกนิซึม และการยังยั้งการดูดซึมกลับของเซโรโทนิน
UA104853C2 (uk) Похідні хроману як модулятори trpv3

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A, E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1929 DE 26/12/2007.